EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.

CSA BrainHealth

2024-02-29T09:35:42+00:00

Coordination and Support Action BrainHealth The CSA BrainHealth addresses the biomedical, economic and societal challenges of diseases and decreased mental health in Europe, aiming for collaborative solutions in prevention, diagnosis and therapies. The overarching goal is to foster and promote global brain health and enhance the well-being of individuals with mental disorders or neurological [...]

PRIME

2024-02-14T15:22:37+00:00

PRIME is an EU-funded project (H2020-EU.3.1.1. - Understanding health, wellbeing and disease) and states that insulin signalling not only affects the body (e.g., diabetes and obesity) but also the brain (e.g., Alzheimer’s disease, autism and obsessive-compulsive disorders).

HEREDITARY

2024-02-14T15:22:49+00:00

Full project name: HetERogeneous sEmantic Data integratIon for the guT-bRain interplaY Funding Programme and Grant Agreement number: Horizon Europe, GA No.  101137074 Duration: 48 months Consortium: Universita Degli Studi di Padova, Sirma Ai Ead, Surf Bv, Stichting Radboud Universitair Medisch Centrum, Observa Associazione, Fundacion Empresa Universidad Gallega, Universita Degli Studi Di Torino, Aalborg Universitet, Katholieke [...]

ETERNITY

2024-02-14T15:23:04+00:00

The “FuEl ThE bRaiN In healtThY aging and agE-relateD diseases” ETERNITY will contribute to the strengthening of the European innovation capacity by training a new generation of researchers with experience and full understanding of the requirements of academia, pharmaceutical and food supplement companies, and the society.

AGORA

2024-02-14T15:23:15+00:00

AGORA is an ERA-NET NEURON-funded project aiming to improve the effectiveness of therapy of chronic neuropathic pain (CNP) and rate of responders in future clinical trials delivering the treatment to targeted subgroups of patients.

Rethinking Schizophrenia

2023-10-31T08:34:38+00:00

Rethinking Schizophrenia Rethinking Schizophrenia is a research-driven project offering tangible policy changes to improve the lives of people living with schizophrenia across Europe. It challenges the status quo and refreshes the European policy debate on people living with schizophrenia and encourages multi-stakeholder-driven policy. The project falls under #BeyondTheVoices campaign. About schizophrenia [...]

Rethinking Migraine

2023-11-06T11:53:52+00:00

Rethinking Migraine in times of COVID-19 RETHINKING Migraine in times of COVID-19 is a research-driven project offering tangible policy changes to improve the lives of people living with migraine across Europe. It challenges the status quo and refreshes the European policy debate on people living with migraine, recognises the consequences of the burdens [...]

RETHINKING Alzheimer’s Disease

2023-04-03T14:58:19+00:00

RETHINKING Alzheimer's disease RETHINKING Alzheimer's disease (AD) is a research-driven project offering policy recommendations to make tangible changes with the aim to improve the lives of people living with Alzheimer’s disease across Europe. About Alzheimer's Disease Alzheimer’s disease is a neurodegenerative disease that progresses in stages, beginning with a long silent phase [...]

The Value of Treatment

2023-06-12T14:20:52+00:00

Identify treatment gaps (or barriers to care) and causing factors along the care pathway and propose solutions to address them. Assess health gains and socio-economic impacts resulting from best practice healthcare interventions, in comparison with current care or no treatment. Converge evidence to policy.

Go to Top